DBV Technologies (DBVT) Common Equity (2012 - 2026)
DBV Technologies (DBVT) posted Common Equity of $148.6 million for Q3 2026, up 180.9% from $52.9 million a year earlier but down 7.4% from the prior quarter.
DBV Technologies (DBVT) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, DBV Technologies' Common Equity came in at $168.8 million, up 516.1% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -3.9% (FY2020 to FY2025).
- In prior years, DBV Technologies' Common Equity was $27.4 million in FY2024 (-80.5%), $140.19 million in FY2023 (-27.9%), $194.45 million in FY2022 (+95.9%) and $99.27 million in FY2021 (-51.7%).
- Quarterly Common Equity has run from a low of $2.9 million in Q1 2025 to a high of $244.42 million in Q2 2022 over five years.
- On a year-over-year basis, Common Equity increased in four of the last seven quarters, with growth averaging 87.4%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 516.1%; the weakest was Q1 2025, with a decline of 97.4%.
- According to Business Quant data, Common Equity for the three prior quarters was $160.4 million (Q2 2026), $207.9 million (Q1 2026) and $168.8 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | DBV Technologies | 1.04 Bn | 274.26 Mn | - | 148.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 148.60 Mn |
| Jun 30, 2026 | 160.40 Mn |
| Mar 31, 2026 | 207.90 Mn |
| Dec 31, 2025 | 168.80 Mn |
| Sep 30, 2025 | 52.90 Mn |
| Jun 30, 2025 | 86.20 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 27.40 Mn |
| Sep 30, 2024 | 54.03 Mn |
| Jun 30, 2024 | 79.10 Mn |
| Mar 31, 2024 | 111.65 Mn |
| Dec 31, 2023 | 140.19 Mn |
| Sep 30, 2023 | 143.99 Mn |
| Jun 30, 2023 | 164.24 Mn |
| Mar 31, 2023 | 179.09 Mn |
| Dec 31, 2022 | 194.45 Mn |
| Sep 30, 2022 | 212.05 Mn |
| Jun 30, 2022 | 244.42 Mn |
| Mar 31, 2022 | 82.06 Mn |
| Dec 31, 2021 | 99.27 Mn |
DBV Technologies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DBVT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DBVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DBVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();